SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: S-3
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea0266812-s3_synergy.htm

Chunk 17 of 26
Word Count: 1484
Character Count: 9798

Document Content:

represents a major growth opportunity, with our dual-benefit RTD formula offering both focus and energy behind a 24+ year brand with strong heritage and awareness in the area of brain health. The FOCUSfactor brand name clearly communicates the differentiation benefit of adding focus to energy. The FOCUSfactor formula does not have to rely as heavily on caffeine as other brands such as Celsius, Bang, Reign and C4, as its formula is a balanced blend of vitamins, cognitive nutrients and caffeine all in a zero sugar, low calorie, great-tasting drink. The brand also delivers a significant value relative to many competitors. Additionally, FOCUSfactor has long-term relationships with large retailers where it has an established presence, which will assist in market penetration for its RTD products. FOCUSfactor is looking to attract both existing consumers of supplement products (typically consumers over age 50) to RTDs as well as a younger demographic (aged 18-49).

FOCUSfactor has successfully
demonstrated the ability to leverage its existing retailer relationships to expand its RTDs. From March 2023 through August 2023,
FOCUSfactor conducted a five-month trial of its RTD products in 44 clubs of a warehouse club retailer throughout Texas with sales
ranging from $550 per club per week to $2,382 per club per week. From April 2024 through July 2024, a second pilot was successfully
completed at a major Canadian club retailer throughout Canada with results ranging from C$378 per club per week to C$2,206 per club per
week.

Our second marquee brand, Flat
Tummy, consists of a range of lifestyle and wellness products and accessories including tea, shakes, lollipops, supplements, apparel,
and exercise accessories. We also provide a Flat Tummy mobile app, which, as of September 30, 2025, had approximately 2 million unique
downloads and is intended as a tool to promote the Flat Tummy lifestyle centered around general wellness and health. Our Flat Tummy brand
consists of 12 SKUs and is sold direct to consumer through the Flat Tummy website and application, as well as through Amazon.com, Target.com,
and iherb.com.

We also own six additional,
non-core brands. While we may elect to promote these brands and commercialize their products in the future, we have prioritized our
key brands, FOCUSfactor and Flat Tummy, and management is focused on the growth of these core products.

Our net revenues by brand for
the nine months ended September 30, 2025 are below:

Net Revenue by Brand for the Nine Months Ended
September 30, 2025

In the United States,
the U.S. Food and Drug Administration (the “FDA”) has regulatory oversight over our FOCUSfactor and Flat Tummy products.
However, no formal FDA approval or registration is required because our products are classified as dietary supplements (most FOCUSfactor
products and some Flat Tummy products) or foods (some FOCUSfactor and Flat Tummy products).

In Canada, Health Canada (“HC”)
has oversight over our FOCUSfactor and Flat Tummy products. Our FOCUSfactor and Flat Tummy products are considered natural health products
by HC so they each have a natural product number that was assigned by HC upon its review and approval.

In the United Kingdom, both
FOCUSfactor and Flat Tummy are considered food supplements that are regulated by the Food Standards Agency. While there is no requirement
for licensing or registering food supplement products in the United Kingdom, products must comply with relevant food law.

In Australia, FOCUSfactor products
are “Listed Medicines” that are regulated by the Therapeutic Goods Administration (“TGA”) and require an AUST
L (Australia Listed Medicine) number, which has been received for some SKUs. Flat Tummy products are classified as either Listed Medicines
or meal replacements. Listed Medicines are regulated by the TGA while meal replacements are regulated under the Australia New Zealand
Food Standards Code.

Our Competitive Strengths

We believe that we have attributes
that differentiate us from our competitors and provide us with significant competitive advantages. Our key competitive strengths include:

Well-Positioned in Growing Categories
Driven by Favorable Consumer Trends

An increased focus on health, beauty and wellness by consumers has
served as a tailwind for our brands. The nutritional supplement market has experienced significant growth across a range of areas including
immune health, brain health, heart health, sleep/stress, and overall nutrition and wellness as a result of an aging population, increased
obesity, pandemic concerns and a desire for more natural solutions and treatments over prescription medication. We believe that we are
well positioned to benefit from these favorable trends. The brain health segment is slated to grow at 8% per year in the United States
and 13% per year globally through 2030, according to Grand View Research. We believe our focus on lifestyle products has also benefited
from the growth and prevalence of social media.

Results Backed by Independent Study for
FOCUSfactor

We believe the FOCUSfactor
brand is strengthened by an independent clinical study to support the product claims for improved memory, concentration, and focus. FOCUSfactor
has been tested in a single-center, randomized, double-blind, placebo-controlled, parallel group study to evaluate its effect on memory,
concentration, and focus in healthy adults. The study was not a clinical trial conducted pursuant to an FDA-approved IND application,
and the FDA has not reviewed this study or evaluated these performance claims.

In this study, FOCUSfactor
was tested on its entire 52-ingredient formulation rather than testing one or two ingredients within a formulation. FOCUSfactor was
shown to provide a 44% increase in recall memory (an increase of 6.5 words compared to 4.5 words for the placebo group) after six weeks
of use versus placebo. This differentiates FOCUSfactor from other brain-health supplements and is a prime reason why FOCUSfactor
has been placed in premier retailers. This controlled study was conducted in healthy male and female subjects between the ages of 18 and
65 who were randomized in a control group and a placebo group. Subjects were compensated for their participation. See “Business — FOCUSfactor
Study” for additional information.

Experienced Management Team with Proven
Track Record of Value Creation

Our executive team has a combined 90 years of experience in consumer
marketing and distribution and has been instrumental in acquiring and building our core brands. Management has exercised strong financial
discipline in its acquisition strategy, with a focus on acquiring brands at attractive valuations. For example, we acquired FOCUSfactor
for approximately 3x trailing EBITDA. For the nine months ended September 30, 2025, year ended December 31, 2024 and the year
ended December 31, 2023, FOCUSfactor generated net revenue of $20.8 million, $30.7 million and $37.2 million, respectively.
Management’s philosophy is to acquire promising brands that fit within our health, beauty and lifestyle offerings, and apply our
marketing and distribution strategies to develop brands to their full potential. We believe we are adept at identifying promising opportunities
that build out and complement our core brand portfolio.

Premier Retail Partners

Our premier retail partners
include Costco, BJ’s Wholesale Club, Walmart, Amazon.com, Publix Supermarkets, Meijer, Albertson’s, CVS, Walgreens and others. We
sell products to these partners under their standard arrangements, which do not include a term or duration, as sales under each vendor
agreement are generally made on a purchase order basis. Our partners provide a platform to expand the breadth of our current offerings
through product line extensions and new product innovation. We continue to introduce new SKUs to our current retail partners, such as
the addition of FOCUSfactor RTDs and vision products to our membership club and other channels. Additionally, the international footprint
of certain of our various retail partners facilitates our geographic expansion plans.

Scalable and Flexible Asset-Light Model
to Support Growth

Our focus is on brand management,
marketing, product development and distribution, and we utilize contract manufacturing partners in order to produce our various brand
offerings. The use of third-party manufacturing partners allows us to scale quickly, as we ensure that our partners have sufficient
capacity to meet our demand needs. We also maintain multiple relationships with different contract manufacturers, ensuring diversification
of our manufacturing base and reducing the likelihood of supply bottlenecks or deficits that could potentially slow our growth.

Our Growth Strategy

We intend to drive growth and
increased profitability in our business through these key elements of our strategy:

Broaden Media Advertising Strategy

We have experienced significant acceleration in sales growth for the
FOCUSfactor brand as a result of our television advertising in prior years. We launched a national advertising campaign in August 2020,
which aired on major news and entertainment networks such as Fox News, CNN, MSNBC, TLC, and TNT, targeting adults 45 years of age
and older. We anticipate a coordinated expansion of our advertising strategy during 2026, as we focus on pushing additional SKUs within
our retail sales partner network to continue to build brand awareness and increase reach for FOCUSfactor. We also plan to invest in online
marketing to promote all of our brands, including social media and influencer driven marketing. We have also experienced significant growth
through our increased distribution, which we continue to drive forward.

Acquire Brands which Complement Our Existing
Portfolio